Literature DB >> 34108530

Human U90926 orthologous long non-coding RNA as a novel biomarker for visual prognosis in herpes simplex virus type-1 induced acute retinal necrosis.

Shintaro Shirahama1, Kenzui Taniue2, Shuhei Mitsutomi2, Rie Tanaka1, Toshikatsu Kaburaki1,3, Tomohito Sato4, Masaru Takeuchi4, Hidetoshi Kawashima5, Yoshihiro Urade2,6, Makoto Aihara1, Nobuyoshi Akimitsu7.   

Abstract

Acute retinal necrosis (ARN) is a form of infectious uveitis caused by alpha herpesviruses, including herpes simplex virus type 1 (HSV-1). We previously found that the long non-coding RNA (lncRNA) U90926 is upregulated in murine retinal photoreceptor cells following HSV-1 infection, leading to host cell death. However, to date, an orthologous transcript has not been identified in humans. We investigated U90926 orthologous transcript in humans and examined its utility as a prognostic marker for visual acuity in patients with ARN. We identified two human orthologous transcripts (1955 and 592 bases) of lncRNA U90926. The amount of the longer human U90926 transcript was approximately 30- and 40-fold higher in the vitreous fluid of patients with ARN than in those with sarcoidosis and intraocular lymphoma, respectively. Furthermore, the expression of the longer human U90926 transcript in the vitreous fluid was highly correlated with the final best-corrected logarithm of the minimum angle of resolution visual acuity in patients with ARN (r = 0.7671, p = 0.0079). This suggests higher expression of the longer human U90926 transcript in the vitreous fluid results in worse visual prognosis; therefore, expression of the longer human U90926 transcript is a potential negative prognostic marker for visual acuity in patients with ARN.

Entities:  

Year:  2021        PMID: 34108530      PMCID: PMC8190147          DOI: 10.1038/s41598-021-91340-x

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


Introduction

Acute retinal necrosis (ARN) is one of the leading causes of blindness in developed countries. It is a type of infectious retinitis caused by members of the alpha herpesvirus subfamily[1]. In a previous study, the main causative viruses of ARN were varicella zoster virus (VZV) (76.1%) and herpes simplex virus (HSV) (15.2%), and ARN caused by HSV was about one-fifth of all cases of ARN caused by VZV[2]. ARN is chiefly diagnosed through viral DNA detection in the intraocular fluid using a high-sensitivity polymerase chain reaction (PCR) assay[1,3]. Although the accurate prediction of visual prognosis is critical to selecting an optimised treatment, biomarkers to predict visual outcomes in patients with ARN are not known. Therefore, it is critical to identify objectively measurable biomarkers that can predict visual prognosis. Long non-coding RNAs (lncRNAs) are a group of functional RNAs that have diverse biological functions and pathogenic roles, such as immune response[4,5], pathogenic infection[6,7], and cancer development[8-11]. In ARN, the neuronal cells of the retina, such as the retinal photoreceptor cells, have been shown to be the primary infected cells[12]. We have previously shown the upregulation of lncRNA U90926 in murine retinal photoreceptor cells post herpes simplex virus type 1 (HSV-1) infection; this upregulation plays a crucial role in HSV-1 proliferation[13]. However, an orthologous U90926 transcript has not been identified in humans to date. Therefore, in this study, we investigated the presence of U90926 orthologous transcripts in humans and examined whether it could be a prognostic marker for visual acuity in patients with ARN caused by HSV-1. Here, we identified two human U90926 orthologous transcripts and found that the expression of the longer transcript was dramatically upregulated in the vitreous fluid from patients with ARN caused by HSV-1. Furthermore, there was high correlation between the expression of the longer human U90926 orthologous transcript in the vitreous fluid and the final best-corrected logarithm of the minimum angle of resolution (logMAR) visual acuity. Our results demonstrate that the expression of the longer human U90926 orthologous transcript could be a potential biomarker for the prognosis of visual acuity in patients with ARN caused by HSV-1.

Results

Identification of human U90926 orthologous transcript

To identify the human ortholog of U90926, we searched the Ensembl genome browser (www.ensembl.org). The mouse U90926 gene is located between Uso1 and Ppef2 on chromosome 5; this gene is evolutionarily conserved between humans and mice (Fig. 1, top). In the human genome, we found that the AC110615.1 gene was annotated on the region located between USO1 and PPEF2 on chromosome 4 (Fig. 1, middle). We also found that AC110615.1 encodes short and long variants, termed AC110615.1-201 (592 bases, 6 exons) and AC110615.1-202 (1,955 bases, 1 exon), respectively (Fig. 1, bottom). Pairwise sequence alignment revealed a sequence similarity of 45.3% between the mouse U90926 transcript and AC110615.1-201 (Supplementary Fig. 1A), and 38.5% between the mouse U90926 transcript and AC110615.1-202 (Supplementary Fig. 1B). We named AC110615.1-201 and AC110615.1-202 as the short and long human U90926 transcripts, respectively.
Figure 1

Human AC110615.1 transcribed from the region between USO1 and PPEF2 on chromosome 4. Schematic representation of the genomic organisation of the region containing mouse U90926 (GRCm38) (top) and human AC110615.1 (GRCh38) (middle), and that of the composition of human AC110615.1 transcript (GRCh38) containing AC110615.1-201 and AC110615.1-202 (bottom).

Human AC110615.1 transcribed from the region between USO1 and PPEF2 on chromosome 4. Schematic representation of the genomic organisation of the region containing mouse U90926 (GRCm38) (top) and human AC110615.1 (GRCh38) (middle), and that of the composition of human AC110615.1 transcript (GRCh38) containing AC110615.1-201 and AC110615.1-202 (bottom).

Upregulation of the long human U90926 transcript in the vitreous fluid from patients with ARN caused by HSV-1

Uveitis is an inflammatory condition of the intraocular tissues, such as the uvea and retina[14], and it is divided into the following three main categories based on aetiology: infectious uveitis, non-infectious uveitis, and masquerade syndrome[15]. Within these categories, ARN is classified as infectious uveitis. We examined the expression levels of the long and short human U90926 transcripts in the vitreous fluid of patients with ARN caused by HSV-1 (a type of infectious uveitis), sarcoidosis (a type of non-infectious uveitis), and intraocular lymphoma (a type of masquerade syndrome). Reverse transcription-quantitative real-time PCR (qRT-PCR) analysis revealed that the expression of the long human U90926 transcript was markedly higher in the vitreous fluid from patients with ARN caused by HSV-1 than from those with sarcoidosis (approximately 30-fold, p = 0.0005) or intraocular lymphoma (approximately 40-fold, p = 0.0005) (Fig. 2, left). The expression of the short human U90926 transcript was almost constant among these three patient groups (Fig. 2, right).
Figure 2

Expression levels of the long and short human U90926 transcripts in the vitreous fluid from patients with acute retinal necrosis, sarcoidosis, and intraocular lymphoma. A reverse transcription-quantitative real-time polymerase chain reaction analysis of the long (upper) and short (lower) human U90926 transcripts in the vitreous fluid of patients with acute retinal necrosis (n = 11), sarcoidosis (n = 5), and intraocular lymphoma (n = 5). Results are expressed as mean ± standard deviation. *p < 0.05.

Expression levels of the long and short human U90926 transcripts in the vitreous fluid from patients with acute retinal necrosis, sarcoidosis, and intraocular lymphoma. A reverse transcription-quantitative real-time polymerase chain reaction analysis of the long (upper) and short (lower) human U90926 transcripts in the vitreous fluid of patients with acute retinal necrosis (n = 11), sarcoidosis (n = 5), and intraocular lymphoma (n = 5). Results are expressed as mean ± standard deviation. *p < 0.05.

High correlation between the expression of the long human U90926 transcript in the vitreous fluid and the final best-corrected logMAR visual acuity in patients with ARN caused by HSV-1

We next examined the relationship between expression of the long human U90926 transcript and visual prognosis in patients with ARN caused by HSV-1. The expression of the long human U90926 transcript in the vitreous fluid was highly correlated with final best-corrected logMAR visual acuity in patients with ARN caused by HSV-1 (correlation analysis using Spearman’s rank-correlation coefficient; r = 0.7671, p = 0.0079) (Fig. 3A, Supplementary Table 2). In contrast, the viral load in the vitreous fluid was not correlated with the final best-corrected logMAR visual acuity (correlation analysis using Spearman’s rank-correlation coefficient; p = 0.5739) (Fig. 3B, Supplementary Table 2). These results indicate that expression of the long human U90926 transcript in the vitreous fluid is an excellent negative biomarker for the visual outcomes of patients with ARN caused by HSV-1, although the viral load is not useful as a predictor of visual acuity.
Figure 3

Correlation analyses among the expression of the long human U90926 transcript, viral loads in the vitreous fluid from patients with acute retinal necrosis caused by herpes simplex virus type 1, and the final best-corrected logarithm of the minimum angle of resolution visual acuity in patients with acute retinal necrosis caused by herpes simplex virus type 1. (A) Relationship between the expression of the long human U90926 transcript in the vitreous fluid and the final best-corrected logarithm of the minimum angle of resolution (logMAR) visual acuity. (B) Relationship between viral loads in the vitreous fluid (log copies/mL) and the final best-corrected logMAR visual acuity. (C) Relationship between the expression of the long human U90926 transcript and viral loads (log copies/mL) in the vitreous fluid.

Correlation analyses among the expression of the long human U90926 transcript, viral loads in the vitreous fluid from patients with acute retinal necrosis caused by herpes simplex virus type 1, and the final best-corrected logarithm of the minimum angle of resolution visual acuity in patients with acute retinal necrosis caused by herpes simplex virus type 1. (A) Relationship between the expression of the long human U90926 transcript in the vitreous fluid and the final best-corrected logarithm of the minimum angle of resolution (logMAR) visual acuity. (B) Relationship between viral loads in the vitreous fluid (log copies/mL) and the final best-corrected logMAR visual acuity. (C) Relationship between the expression of the long human U90926 transcript and viral loads (log copies/mL) in the vitreous fluid.

Moderate correlation between the expression of the long human U90926 transcript and the viral load in the vitreous fluid from patients with ARN caused by HSV-1

The expression of the long human U90926 transcript in the vitreous fluid of patients with ARN caused by HSV-1 was moderately correlated with the viral load in the vitreous fluid (correlation analysis using Spearman’s rank-correlation coefficient; r = 0.6115, p = 0.0499) (Fig. 3C, Supplementary Table 2). This result suggests that expression of the long human U90926 transcript reflects the viral load in the vitreous fluid.

Discussion

In this study, we identified long and short human U90926 transcripts based on high sequence similarities to the mouse U90926 transcript and found that the long human U90926 transcript was dramatically upregulated in the vitreous fluid of patients with ARN caused by HSV-1. Furthermore, in patients with ARN caused by HSV-1, we demonstrated that there was a high correlation between the expression of the human long U90926 transcript in the vitreous fluid and the final best-corrected logMAR visual acuity as well as a moderate correlation between the expression of the long human U90926 transcript and the viral load in the vitreous fluid. Retinal photoreceptor cells are divided into two major types: cone and rod cells. In humans, cone cells are responsible for colour vision and high visual acuity. Consequently, the death of cone cells leads to significant vision loss[16]. We previously showed that the mouse U90926 transcript was dramatically upregulated in 661W cells derived from cone cells post HSV-1 infection[13]. In 661W cells, lncRNA U90926 acted as a major contributor to host cell death by promoting HSV-1 proliferation[13]. Considering these results, we presumed that upregulated expression of the long human U90926 transcript in the vitreous fluid reflected an increase in the number of infected cone cells, which in turn induced cone cell death by promoting viral proliferation. Consequently, the expression of the long human U90926 transcript might reflect the visual prognosis in patients with ARN caused by HSV-1. Although the detailed mechanism underlying this strong correlation between upregulated expression of the long human U90926 transcript and the final best-corrected logMAR visual acuity remains unclear, our results highlight the usefulness of measuring the expression of the long human U90926 transcript in assessing the prognosis of visual acuity in patients with ARN caused by HSV-1. In this study, all patients with ARN caused by HSV-1 were treated with systemic acyclovir therapy before the vitreous fluid was collected. Therefore, we had to consider the possibility that the viral load may have decreased at the time of the vitreous fluid collection due to the acyclovir therapy. However, there was a moderate correlation between the expression of the long human U90926 transcript and the viral load in the vitreous fluid. If the vitreous fluid prior to systemic acyclovir treatment had been used for analysis, it is possible that there would have been an even stronger correlation between the expression of the long human U90926 transcript and the viral load in the vitreous fluid.

Methods

Sequence alignment

Pairwise sequence alignment was performed using Clustal Omega[17].

Patients

This study was approved by the Research Ethics Committee of the Graduate School of Medicine and Faculty of Medicine at the University of Tokyo and National Defense College Hospital [No.10984-(6)]. Written informed consent was obtained from all patients. All procedures were performed in accordance with the principles of the Declaration of Helsinki. This study included a total of 21 eyes of 21 patients (12 males and 9 females; average age = 59.0 ± 18.1 years) who underwent pars plana vitrectomy for the diagnosis and/or treatment of ARN, sarcoidosis, and intraocular lymphoma in the University of Tokyo Hospital and National Defense Medical College Hospital between December 2013 and December 2018. There were 8 patients (11 eyes) diagnosed with ARN caused by HSV-1 (7 males and 4 females; average age = 53.5 ± 16.7 years), 5 patients (5 eyes) with sarcoidosis (2 males and 3 females; average age = 57.0 ± 20.0 years), and 5 patients (5 eyes) with intraocular lymphoma (3 males and 2 females; average age = 73.2 ± 14.0 years). The diagnoses of ARN, sarcoidosis, and intraocular lymphoma were made according to certain diagnostic criteria. A diagnosis of ARN was based on the previously reported criteria for ARN in Japan[3]. For sarcoidosis, we used the diagnostic criteria established by the International Workshop on Ocular Sarcoidosis[18]. An intraocular lymphoma diagnosis was made if at least two of the following four criteria were met: (1) the result of cytological diagnosis based on Papanicolaou’s classification using Papanicolaou-stained cytological preparations was greater than class III[19]; (2) interleukin (IL)-10/IL-6 ratio > 1, or IL-10 > 50 pg/mL in the intraocular fluid[20,21]; (3) strong deviation in the free light chain κ/λ ratio on fluorescence-activated cell sorting analysis[22]; and (4) positive PCR results for immunoglobulin heavy-chain gene rearrangement[23-25].

Collection of vitreous fluid and measurement of viral loads in the vitreous fluid

A standard 3-port 23-gauge or 25-gauge vitrectomy was performed, and vitreous fluid was collected aseptically without dilution. The collected vitreous fluid was stored immediately in a pre-sterilised cryotube at − 80 °C. DNA was extracted from each vitreous fluid, and then multiplex quantitative PCR assay for viral DNA (HSV-1, HSV-2, varicella zoster virus, Epstein–Barr virus, cytomegalovirus, human herpesvirus 6, human herpesvirus 7, and human herpesvirus 8) was performed as previously described[26].

RNA extraction and quality control

Total RNA from the vitreous fluid was extracted using a NucleoSpin miRNA plasma kit (Macherey–Nagel, Duren, Germany). The assessment of total RNA quality was performed on an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA) using an RNA 6000 Pico Kit (Agilent Technologies). Samples with an RNA integrity number of ≥ 7.0 were used in this study.

Reverse transcription-quantitative real-time polymerase chain reaction analysis

Total RNA was reverse transcribed into cDNA using Prime Script RT Master Mix (TaKaRa Bio, Shiga, Japan). The cDNA was amplified using both the specific primer sets listed in Supplementary Table 1 and SYBR Premix Ex Taq II (TaKaRa Bio) in accordance with the manufacturer’s instructions. The qPCR was then performed using a Thermal Cycler Dice Real Time System (TaKaRa Bio). GAPDH mRNA was used for transcript normalisation. The relative RNA amount of AC 110615.1 transcript in the vitreous fluid from patients with ARN caused by HSV-1and sarcoidosis was calculated based on that in the vitreous fluid from patients with intraocular lymphoma.

Measurement of visual acuity

Decimal visual acuity was measured using a Landolt ring, and then converted to logMAR visual acuity using the following formula: logMAR visual acuity = log (1/decimal visual acuity). As previously described[27], logMAR visual acuity of finger counting, motus manus, and light sense was defined as 2.4, 2.7, and 3.0, respectively. A higher logMAR value indicates lower visual activity.

Statistical analysis

Values were presented as median with interquartile range. Comparison of continuous variables between the two groups was performed using Mann–Whitney U-test. Correlation between two variables was analysed using Spearman’s rank-correlation coefficient. A p value < 0.05 was considered statistically significant. Both Mann–Whitney U-test and correlation analysis were performed using GraphPad Prism version 7 (GraphPad Software, San Diego, CA). Supplementary Information 1. Supplementary Information 2. Supplementary Information 3. Supplementary Information 4. Supplementary Information 5.
  25 in total

1.  B cell clonality of primary central nervous system and primary intraocular lymphomas.

Authors:  Kouichi Ohta; Kenji Sano; Takefumi Suzuki; Eiko Hidaka; Akiko Yoshida; Takanobu Kikuchi
Journal:  Jpn J Ophthalmol       Date:  2007-04-06       Impact factor: 2.447

2.  Long noncoding RNA NEAT1-dependent SFPQ relocation from promoter region to paraspeckle mediates IL8 expression upon immune stimuli.

Authors:  Katsutoshi Imamura; Naoto Imamachi; Gen Akizuki; Michiko Kumakura; Atsushi Kawaguchi; Kyosuke Nagata; Akihisa Kato; Yasushi Kawaguchi; Hiroki Sato; Misako Yoneda; Chieko Kai; Tetsushi Yada; Yutaka Suzuki; Toshimichi Yamada; Takeaki Ozawa; Kiyomi Kaneki; Tsuyoshi Inoue; Mika Kobayashi; Tatsuhiko Kodama; Youichiro Wada; Kazuhisa Sekimizu; Nobuyoshi Akimitsu
Journal:  Mol Cell       Date:  2014-02-06       Impact factor: 17.970

3.  ASBEL-TCF3 complex is required for the tumorigenicity of colorectal cancer cells.

Authors:  Kenzui Taniue; Akiko Kurimoto; Yasuko Takeda; Takeshi Nagashima; Mariko Okada-Hatakeyama; Yuki Katou; Katsuhiko Shirahige; Tetsu Akiyama
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-21       Impact factor: 11.205

4.  Combined intravitreal methotrexate and immunochemotherapy followed by reduced-dose whole-brain radiotherapy for newly diagnosed B-cell primary intraocular lymphoma.

Authors:  Toshikatu Kaburaki; Kazuki Taoka; Junko Matsuda; Hideomi Yamashita; Izuru Matsuda; Hideki Tsuji; Rie Tanaka; Kumi Nakazaki; Fumihiko Nakamura; Kohei Kamiya; Mineo Kurokawa; Kuni Ohtomo; Makoto Aihara
Journal:  Br J Haematol       Date:  2017-07-12       Impact factor: 6.998

5.  Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis.

Authors:  Manabu Mochizuki; Justine R Smith; Hiroshi Takase; Toshikatsu Kaburaki; Nisha R Acharya; Narsing A Rao
Journal:  Br J Ophthalmol       Date:  2019-02-23       Impact factor: 4.638

6.  Analysis of clonal immunoglobulin heavy chain rearrangements in ocular lymphoma.

Authors:  Joachim M Baehring; Sofia Androudi; Janina J Longtine; Rebecca A Betensky; Jeffrey Sklar; C Stephen Foster; Fred H Hochberg
Journal:  Cancer       Date:  2005-08-01       Impact factor: 6.860

7.  Diagnostic testing of vitrectomy specimens.

Authors:  Janet L Davis; Daniel M Miller; Phillip Ruiz
Journal:  Am J Ophthalmol       Date:  2005-11       Impact factor: 5.258

8.  IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma.

Authors:  Nathalie Cassoux; Alain Giron; Bahram Bodaghi; Thi H C Tran; Sylvie Baudet; Fréderic Davy; Chi C Chan; Phuc Lehoang; Hélène Merle-Béral
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-07       Impact factor: 4.799

9.  Long noncoding RNA UPAT promotes colon tumorigenesis by inhibiting degradation of UHRF1.

Authors:  Kenzui Taniue; Akiko Kurimoto; Hironobu Sugimasa; Emiko Nasu; Yasuko Takeda; Kei Iwasaki; Takeshi Nagashima; Mariko Okada-Hatakeyama; Masaaki Oyama; Hiroko Kozuka-Hata; Masaya Hiyoshi; Joji Kitayama; Lumi Negishi; Yoshihiro Kawasaki; Tetsu Akiyama
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-14       Impact factor: 11.205

10.  Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega.

Authors:  Fabian Sievers; Andreas Wilm; David Dineen; Toby J Gibson; Kevin Karplus; Weizhong Li; Rodrigo Lopez; Hamish McWilliam; Michael Remmert; Johannes Söding; Julie D Thompson; Desmond G Higgins
Journal:  Mol Syst Biol       Date:  2011-10-11       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.